It was demonstrated that C3 glomerulopathy is associated with elevated levels of urinary complement proteins (C3, C4, FB, properdin, and C5) and complement activation products (C3a, Ba, Bb, C5a, and soluble C5b-9). This evidence concerns the gene C3 and complement 3 glomerulopathy.